0001209191-23-056836.txt : 20231128
0001209191-23-056836.hdr.sgml : 20231128
20231128190009
ACCESSION NUMBER: 0001209191-23-056836
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231126
FILED AS OF DATE: 20231128
DATE AS OF CHANGE: 20231128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Szwarcberg Javier B.
CENTRAL INDEX KEY: 0001903669
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39594
FILM NUMBER: 231447992
MAIL ADDRESS:
STREET 1: 2001 JUNIPERO SERRA BOULEVARD, SUITE 640
CITY: DALY CITY
STATE: CA
ZIP: 94014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001683553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812154263
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BOULEVARD, SUITE 740
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (415) 655-4168
MAIL ADDRESS:
STREET 1: 611 GATEWAY BOULEVARD, SUITE 740
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-26
0
0001683553
SPRUCE BIOSCIENCES, INC.
SPRB
0001903669
Szwarcberg Javier B.
C/O SPRUCE BIOSCIENCES, INC.
611 GATEWAY BOULEVARD, SUITE 740
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
Chief Executive Officer
0
Employee Stock Option (right to buy)
4.59
2023-11-26
4
A
0
125000
0.00
A
2023-11-26
2032-01-02
Common Stock
125000
125000
D
On January 3, 2022, the Reporting Person was granted a stock option to purchase 250,000 shares of the Issuer's common stock. The shares subject to the stock option shall vest upon the achievement of specified performance goals, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan). Certain specified performance goals were met, resulting in the vesting of 125,000 shares subject to the stock option.
/s/ Samir M. Gharib, Attorney-in-Fact
2023-11-28